Related Experiment Videos
Onychomycosis. Agents of choice
1St. John's Institute of Dermatology, Guy's Hospital, London, United Kingdom.
Dermatologic Clinics
|January 1, 1993
Summary
Onychomycosis treatment has evolved with new evidence and topical agents. Comparative studies are lacking, making treatment choices based on experience rather than data.
Area of Science:
- Dermatology
- Mycology
- Infectious Diseases
Background:
- Onychomycosis management has seen significant recent changes.
- Trends include improved evidence, broader infection coverage, shorter oral therapies, and new topical agents.
- Current treatment selection relies heavily on clinical experience due to a lack of comparative data.
Purpose of the Study:
- To review current trends in onychomycosis management.
- To highlight the need for comparative studies to guide evidence-based treatment choices.
Main Methods:
- Review of recent advancements in onychomycosis treatment.
- Analysis of emerging trends in therapeutic approaches.
Main Results:
- Significant evolution in onychomycosis treatment strategies observed.
- Introduction of novel topical therapies for nail fungal infections.
- Shortening of systemic (oral) therapy durations noted.
Conclusions:
- The current landscape of onychomycosis treatment is dynamic.
- A critical need exists for comparative research to inform optimal therapeutic decisions.
- Future studies are anticipated to provide data for evidence-based dermatological practice.